These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Significance of determination of ceruloplasmin level in the diagnosis of rheumatic activity]. Botsiurko VI Vrach Delo; 1977 Jan; (1):36-8. PubMed ID: 300525 [No Abstract] [Full Text] [Related]
6. [Diagnostic significance of quantitative determination of C-reactive protein in rheumatic diseases]. Mitrofanova TA; Riazantseva TA; Ivanova SM; Speranskiĭ AI Klin Med (Mosk); 1986 May; 64(5):76-80. PubMed ID: 3487676 [No Abstract] [Full Text] [Related]
7. [Behavior of the fractionation curve of blood acid mucopolysaccharide in various rheumatic diseases]. Ghirardo G; Rovetta G Reumatismo; 1968; 20(2):118-20. PubMed ID: 4248158 [No Abstract] [Full Text] [Related]
8. [Clinico-chemical and hematological findings in inflammatory and symptomatic rheumatic diseases]. Paschben K; Ludwig U Z Allgemeinmed; 1973 Aug; 49(23):1077-82. PubMed ID: 4125968 [No Abstract] [Full Text] [Related]
9. Incidence of the anti-nuclear factor in human sera. ALEXANDER WR; BREMNER JM; DUTHIE JJ Ann Rheum Dis; 1960 Dec; 19(4):338-50. PubMed ID: 13682375 [No Abstract] [Full Text] [Related]
10. Plasma glucosamine and its pathological changes. JIMENEZ DIAZ C; AGUIRRE M; ARJONA E Bull Inst Med Res Univ Madr; 1953; 6(4):136-54. PubMed ID: 13230684 [No Abstract] [Full Text] [Related]
11. Investigation of rheumatic and connective tissue diseases. Webb J; Wells JV Med J Aust; 1979 Apr; 1(S2):7-12. PubMed ID: 377032 [No Abstract] [Full Text] [Related]
12. [Determination of uropepsinogen in the treatment of rheumatic diseases]. Coari G; D'Ottavio D; Panzini P Clin Ter; 1979 Mar; 88(6):621-9. PubMed ID: 313870 [No Abstract] [Full Text] [Related]
13. The level of some inorganic elements in the sera of rheumatic children. al-Nagdy SA; Khattab AK; el-Fattah MM J Trop Med Hyg; 1972 Dec; 75(12):237-9. PubMed ID: 4539606 [No Abstract] [Full Text] [Related]
14. [Qualitative and quantitative research on seromucoid in the course of collagen diseases and degenerative arthropathies]. Scalabrino R; Franzini C; Rossi L Reumatismo; 1966; 18(6):501-5. PubMed ID: 5997091 [No Abstract] [Full Text] [Related]
15. [Level of antistreptolysin O (ASO) in various pathological conditions connected with the locomotor system]. Cam HD Reumatologia; 1975; 13(3):201-6. PubMed ID: 1179063 [No Abstract] [Full Text] [Related]
16. [Metabolism of trace elements and activity of their associated metalloproteins in rheumatism]. Neĭko EM; Botsiurko VI Vrach Delo; 1981 Jun; (6):36-8. PubMed ID: 6789555 [No Abstract] [Full Text] [Related]
17. PAF, a potent proinflammatory mediator, looking for its role in the pathogenesis of joint damage. Herrero-Beaumont G; Egido J Ann Rheum Dis; 1997 Apr; 56(4):211-3. PubMed ID: 9165991 [No Abstract] [Full Text] [Related]
18. [Ceruloplasmin and immunoglobulins under controlled D-penicillamine therapy in rheumatoid arthritis]. Schmidt KL; Ott VR Z Rheumatol; 1976; 35(3-4):154-63. PubMed ID: 1266422 [TBL] [Abstract][Full Text] [Related]
19. [On the diagnosis of the activity of chronic rheumatic diseases, with special reference to the quantitative determination of haptoglobins and caeruloplasmin]. MULLER W; KLUTHE R; MULLER H Z Rheumaforsch; 1963 Feb; 22():1-10. PubMed ID: 13936553 [No Abstract] [Full Text] [Related]